CollPlant Email Format

Biotechnology ResearchCentral District, Israel51-200 Employees

CollPlant is a biotechnology company based in Rehovot, Israel, focused on regenerative and aesthetic medicine. It has developed a plant-derived recombinant human Type I collagen (rhCollagen) that is identical to the collagen produced by the human body, enabling scalable production for tissue regeneration and organ manufacturing. This rhCollagen serves as a foundational biomaterial for applications in 3D bioprinting of tissues and organs, as well as medical aesthetics.

Its customers include researchers and developers in regenerative medicine and medical aesthetics who seek a non-animal-derived collagen source. Positioned in the biotechnology research space, the company emphasizes plant-based production to meet demand for rhCollagen as a biomaterial for tissue engineering. In 2026, CollPlant reported first-quarter results and provided a corporate update, and it also disclosed the termination of its development agreement with AbbVie.

Sign up for free to view info

Company overview Employee directory